节点文献

全身分次放射治疗血液恶性肿瘤的临床研究

Clinical study of fractionated total body irradiation in hematological malignancies

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 姚原张松方屠永青陆冬青王雅杰

【Author】 YAO Yuan1,ZHANG Songfang2,TU Yongqing2,LU Dongqing2,WANG Yajie3 1Department of Radiooncology,NO.3 People’s Hospital of Shanghai Jiaotong University School of Medicine,Shanghai 201900,China;2Department of Oncology,Xinhua Hospital of Shanghai Jiaotong University School of Medicine,Shanghai 200092,China;3Department of Oncology,Changhai Hospital of the Second Military Medical University,Shanghai 200433,China.

【机构】 上海交通大学医学院附属第三人民医院上海交通大学医学院附属新华医院肿瘤科第二军医大学附属长海医院肿瘤科

【摘要】 目的:观察接受分次全身放射治疗的血液恶性肿瘤患者的早晚期毒性反应及预后。方法:对14例血液恶性肿瘤患者进行分次全身放射治疗,作为异基因骨髓移植的预处理。结果:14名患者均能顺利完成全身分割放射治疗,早期急性反应均能耐受。经过一年以上随访,1年生存率为57%(8/14),5年生存率为37%(3/8)。结论:患者对分次全身放射治疗具有良好的耐受性,可以作为异基因骨髓移植的重要预处理手段在临床上广泛应用。

【Abstract】 Objective:To evaluate the acute side effects and late toxicities of fractionated total body irradiation(FTBI) and the survival in the treatment of hematological malighancies of patients.Methods:FTBI had play an role in preparative cytoreductive regimens for bone marrow transplantation(BMT) and were performed in 14 patients with hematological malignancies.Results:All 14 patients were successfully finished FTBI,and the acute side effects were lower.1 years survival rate was 57%(8/14),5 year survival rate 37%(3/8).Conclusion:The patients have satisfactory tolerance with FTBI.FTBI could been a major component in preparative regimen for allogeneic bone marrow transplantation in the treatment of hematological malignancies.

【基金】 上海市重点学科建设项目资助(编号:B905)
  • 【文献出处】 现代肿瘤医学 ,Journal of Modern Oncology , 编辑部邮箱 ,2012年07期
  • 【分类号】R733
  • 【被引频次】2
  • 【下载频次】45
节点文献中: 

本文链接的文献网络图示:

本文的引文网络